Demirkol, S. Et Al. 2017. A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.. Journal of Cancer , vol.8 , 1113-1122.

Demirkol, S., GOMCELI, I., ISBILEN, M., DAYANC, B., TEZ, M., BOSTANCI, E. Ö., ... TURHAN, N.(2017). A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.. Journal of Cancer , vol.8, 1113-1122.

Demirkol, SEÇİL Et Al. "A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.," Journal of Cancer , vol.8, 1113-1122, 2017

Demirkol, SEÇİL D. Et Al. "A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.." Journal of Cancer , vol.8, pp.1113-1122, 2017

Demirkol, S. Et Al. (2017) . "A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.." Journal of Cancer , vol.8, pp.1113-1122.

@article{article, author={SEÇİL DEMİRKOL CANLI Et Al. }, title={A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.}, journal={Journal of Cancer}, year=2017, pages={1113-1122} }